Elsevier

Annals of Oncology

Volume 19, Issue 12, December 2008, Pages 1992-1999
Annals of Oncology

reviews
Primary extranodal lymphomas of stomach: clinical presentation, diagnostic pitfalls and management

https://doi.org/10.1093/annonc/mdn525Get rights and content
Under an Elsevier user license
open archive

Abstract

Gastrointestinal lymphoma is the most common form of extranodal lymphoma, accounting for 30%–40% of cases. The most commonly involved site is the stomach (60%–75% of cases), followed by the small bowel, ileum, cecum, colon and rectum. The most common histological subtypes are diffuse large B-cell lymphoma (DLBCL) and marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT). Helicobacter pylori infection has been implicated in the pathogenesis of MALT gastric lymphoma, but its role in gastric diffuse large B-cell non-Hodgkin's lymphoma (NHL) is controversial. The therapeutic approach for patients with gastric NHL has been revised over the last 10 years. Conservative treatment with anthracycline-based chemotherapy alone or in combination with involved-field radiotherapy has replaced gastrectomy as standard therapy in cases with DLBCL. Additionally, MALT lymphomas are mainly treated with antibiotics alone, which can induce lasting remissions in those cases associated with H. pylori infection. Nevertheless, various therapeutic aspects for primary gastric lymphomas are still controversial and several questions remain unanswered. Among others, the role of rituximab, consolidation radiotherapy as well as H. pylori eradication in histological aggressive subtypes warrants better clarification.

Key words

diffuse large B-cell lymphomas
extranodal lymphomas
Helicobacter pylori infection
mucosa-associated lymphoid tissue
primary gastric lymphomas

Cited by (0)